23 December 2016 - Congressional reports can be a snooze. But that is not how I’d characterise Wednesday’s in-depth account of price gouging among prescription drug makers. 

The 130-page narrative prepared by the United States Senate Special Committee on Aging was juicy, detailing how four pharmaceutical companies have taken advantage of our health care system to enrich themselves and their executives, harming patients and taxpayers.

Susan Collins, a Republican from Maine who is chairwoman of the committee, and Claire McCaskill, a Democrat from Missouri who is its ranking member, published the report. But in a statement, they said their work was not finished and called for “continued efforts to stop bad actors who are acquiring drugs that have been off-patent for decades and driving up their prices solely because they can.”

Read New York Times article